Clinical research priorities in renal cell carcinoma: renal cell carcinoma chemoprevention strategies including target populations, proposed agents, and clinical trial designs--Workgroup No. 6. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).
Hanash
K A
KA
Department of Urology, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Aquilina
J W
JW
Barrett
D M
DM
Blute
M L
ML
Cockett
A T
AT
Corica
F A
FA
Hillman
G G
GG
Zbar
B
B
Zhuang
Z
Z
D014408:Biomarkers, Tumor / Q000235:genetics; D002292:Carcinoma, Renal Cell / Q000517:prevention & control*; D018890:Chemoprevention; D002986:Clinical Trials as Topic; D015316:Genetic Therapy; D006292:Health Priorities; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D016898:Interferon-alpha / Q000008:administration & dosage; D007376:Interleukin-2 / Q000008:administration & dosage; D007680:Kidney Neoplasms / Q000517:prevention & control*; D018579:Patient Selection; D012107:Research Design
D014408:Biomarkers, Tumor; D016898:Interferon-alpha; D007376:Interleukin-2